145 King Street West, Suite 2200 | Toronto, Ontario | M5H 4G2 | 416 362 3711
Minden Gross LLP is a full service business law firm that acts in partnership with clients to achieve creative and effective solutions to their business needs.
Read More ...
p: (416) 369-4140
Minden Gross LLP is primarily business-oriented, providing representation and assistance in the three broad areas of real estate, corporate and commercial transactional and litigation services.
Minden Gross is a well respected mid-size firm. We are large enough to offer firm members all the support, training, and services provided by larger firms, while also providing a warm and congenial working environment.
145 King Street West
Suite 2200 (Reception), Suite 2100 (Deliveries)
Telephone: (416) 362-3711
Fax Number: (416) 864-9223
Minden Gross LLP has implemented a vaccination and visitation policy for our office and its visitors. Read: https://www.mindengross.com/our-firm/minden-gross-llp-vaccination-and-office-visitation-policy
May 17, 2019
Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) closed its previously announced (May 8, 2019) acquisition of an 80% equity interest in Pharmadrug Production GmbH (“Pharmadrug”) for total consideration of €5.0 million. Pharmadrug is a cash flow positive German pharmaceutical distribution company with over 20 years of operating history and a Schedule I European Union narcotics license allowing for the distribution of medical cannabis to pharmacies in Germany and throughout the Eurozone as markets become legalized. Pharmadrug has supply agreements in place with Bedrocan International B.V., Canadian Licensed Producers, and is currently supplying medical cannabis to pharmacies in Germany. Minden Gross LLP acted for Aura in the purchase of Pharmadrug with a team led by Andrew Elbaz (Partner, Securities & Capital Markets), David Judson (Partner, Securities & Capital Markets), and Alexander Katznelson (Associate, Securities & Capital Markets).